Fatemeh Sadat Rashidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatemeh Sadat Rashidi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Afagh Alavi
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
2 shared publications - Ehsan Ahmadipour
Neuroscience Research Center, Institute of Neuroscience and Cognition, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Abbas Bagher
Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Abolhassan Ahmadiani
Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Ali Akabar Asadi-Pooya
Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, USA
1 shared publication Hamed Javadian
Functional Neurosurgery Research Center, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Ira
1 shared publication
Latest Publications
- Open Access
- 24 December 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 17 (1) , 135-142
An Autosomal Dominant TUBB3 Mutation Associated with Congenital Fibrosis of the Extraocular Muscles Type 3 in an Iranian Family
Congenital fibrosis of the extraocular muscles type 3 (CFEOM3) is a congenital cranial dysinnervation disorder marked by variable ophthalmoplegia and ptosis with considerable phenotypic heterogeneity. We report a large multigenerational Iranian family with autosomal dominant CFEOM3. Affected individuals underwent comprehensive ophthalmologic evaluation. Whole-exome sequencing in the proband, followed by Sanger sequencing in ten affected and four unaffected relatives, identified a heterozygous missense variant, c.784C>T (p.Arg262Cys), in exon 4 of TUBB3 (16q24.3), which co-segregated with the disease phenotype. Cranial magnetic resonance imaging (MRI) in two affected individuals revealed asymmetric basal ganglia morphology, predominantly affecting the caudate nuclei and putamen. At the level of the anterior commissure, the bilateral CFEOM3 patient lacked a visible commissure, whereas the unilateral patient exhibited a thin but identifiable structure. Midline sagittal imaging demonstrated corpus callosum dysgenesis in both individuals, with slightly greater involvement of the corpus callosum body in the unilateral case, though this difference was not radiologically significant. Despite differences in ocular phenotype, overall cerebral involvement was largely comparable. These findings confirm the pathogenic role of the TUBB3 p.Arg262Cys variant in CFEOM3A and extend the spectrum of ophthalmologic and neuroimaging abnormalities within an extended family. The results highlight the complex genotype–phenotype relationships in TUBB3-related disease and underscore the importance of integrated clinical and molecular evaluation for precise diagnosis.
- 24 December 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 17 (1) , 135-142
Open AccessAn Autosomal Dominant TUBB3 Mutation Associated with Congenital Fibrosis of the Extraocular Muscles Type 3 in an Iranian Family
Congenital fibrosis of the extraocular muscles type 3 (CFEOM3) is a congenital cranial dysinnervation disorder marked by variable ophthalmoplegia and ptosis with considerable phenotypic heterogeneity. We report a large multigenerational Iranian family with autosomal dominant CFEOM3. Affected individuals underwent comprehensive ophthalmologic evaluation. Whole-exome sequencing in the proband, followed by Sanger sequencing in ten affected and four unaffected relatives, identified a heterozygous missense variant, c.784C>T (p.Arg262Cys), in exon 4 of TUBB3 (16q24.3), which co-segregated with the disease phenotype. Cranial magnetic resonance imaging (MRI) in two affected individuals revealed asymmetric basal ganglia morphology, predominantly affecting the caudate nuclei and putamen. At the level of the anterior commissure, the bilateral CFEOM3 patient lacked a visible commissure, whereas the unilateral patient exhibited a thin but identifiable structure. Midline sagittal imaging demonstrated corpus callosum dysgenesis in both individuals, with slightly greater involvement of the corpus callosum body in the unilateral case, though this difference was not radiologically significant. Despite differences in ocular phenotype, overall cerebral involvement was largely comparable. These findings confirm the pathogenic role of the TUBB3 p.Arg262Cys variant in CFEOM3A and extend the spectrum of ophthalmologic and neuroimaging abnormalities within an extended family. The results highlight the complex genotype–phenotype relationships in TUBB3-related disease and underscore the importance of integrated clinical and molecular evaluation for precise diagnosis.
- Open Access
- 21 March 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (2) , 479-486
Potential role of FKBP5 single‐nucleotide polymorphisms in functional seizures
Objective: We investigated the associations between FKBP5 single‐nucleotide polymorphisms (SNPs) and functional seizures (FS).Methods: Seventy patients with FS, 140 with major depressive disorder (MDD), and 140 healthy controls were studied. Their DNAs were analyzed for the rs1360780 in the 3′ region and rs9470080 in the 5′ region of the FKBP5. Childhood trauma questionnaire and hospital anxiety and depression scale were used.Results: Patients with FS and those with MDD had less GG and more AA genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. Similar results were observed for allelic frequencies. There were no significant differences between FS and MDD groups in terms of genotype and allelic frequencies for both SNPs. The results of multinomial logistic regression analysis showed that FKBP5 polymorphisms were not associated with the diagnosis.Significance: Patients with FS and those with MDD had significantly different genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. However, it seems that FKBP5 polymorphisms were not associated with FS in the absence of depression. Further genetic investigations of patients with FS may increase our understanding of the neurobiological underpinnings of this condition, but such studies should be large enough and very well designed; they should include a comparison group with depression in addition to a healthy control group.
- 21 March 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (2) , 479-486
Open AccessPotential role of FKBP5 single‐nucleotide polymorphisms in functional seizures
Objective: We investigated the associations between FKBP5 single‐nucleotide polymorphisms (SNPs) and functional seizures (FS).Methods: Seventy patients with FS, 140 with major depressive disorder (MDD), and 140 healthy controls were studied. Their DNAs were analyzed for the rs1360780 in the 3′ region and rs9470080 in the 5′ region of the FKBP5. Childhood trauma questionnaire and hospital anxiety and depression scale were used.Results: Patients with FS and those with MDD had less GG and more AA genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. Similar results were observed for allelic frequencies. There were no significant differences between FS and MDD groups in terms of genotype and allelic frequencies for both SNPs. The results of multinomial logistic regression analysis showed that FKBP5 polymorphisms were not associated with the diagnosis.Significance: Patients with FS and those with MDD had significantly different genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. However, it seems that FKBP5 polymorphisms were not associated with FS in the absence of depression. Further genetic investigations of patients with FS may increase our understanding of the neurobiological underpinnings of this condition, but such studies should be large enough and very well designed; they should include a comparison group with depression in addition to a healthy control group.
- Open Access
- 1 December 2021
- Published by CMV Verlag in Physiology and Pharmacology
- Vol. 25 (4) , 296-305
Association of two specific haplotypes of serotonin transporter gene with fluvoxamine treatment outcomein Iranian patients with obsessive compulsive disorder
Introduction: Converging lines of evidence indicate that serotonin transporter has a role in response to selective serotonin reuptake inhibitors pharmacotherapy in a variety of neuropsychiatric disorders. In the present study, the association of four functional loci of the serotonin transporter gene (SLC6A4) with fluvoxamine treatment outcome in Iranian patients with obsessive compulsive ...
- 1 December 2021
- Published by CMV Verlag in Physiology and Pharmacology
- Vol. 25 (4) , 296-305
Open AccessAssociation of two specific haplotypes of serotonin transporter gene with fluvoxamine treatment outcomein Iranian patients with obsessive compulsive disorder
Introduction: Converging lines of evidence indicate that serotonin transporter has a role in response to selective serotonin reuptake inhibitors pharmacotherapy in a variety of neuropsychiatric disorders. In the present study, the association of four functional loci of the serotonin transporter gene (SLC6A4) with fluvoxamine treatment outcome in Iranian patients with obsessive compulsive ...